BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

523620

PHRMASI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PHAARMASIA LTD. Share Price Update

As of the latest trading session, PHAARMASIA LTD. share price is currently at ₹ 49.08, which is up by ₹ 2.33 from its previous closing. Today, the stock has fluctuated between ₹ 46.76 and ₹ 49.08. Over the past year, PHAARMASIA LTD. has achieved a return of 5.70 %. In the last month alone, the return has been 36.33 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PHAARMASIA LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    33.50

  • P/E Ratio (TTM)

    43.05

  • Beta

    0.40

  • Book Value / share

    9.52

  • Return on equity

    0.00%

  • EPS (TTM)

    1.14

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.74

info icon alternate text

PHAARMASIA LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 16.55
Operating Expense 14.99
Net Profit 1.74
Net Profit Margin (%) 10.51
Earnings Per Share (EPS) 2.54
EBITDA 1.75
Effective Tax Rate (%) -2.35
Particulars JUN 2025 (Values in Cr)
Revenue 6.87
Operating Expense 6.88
Net Profit 0.27
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.40
EBITDA 0.39
Effective Tax Rate (%) 12.90
Particulars MAR 2025 (Values in Cr)
Revenue 5.43
Operating Expense 6.13
Net Profit -0.53
Net Profit Margin (%) -9.76
Earnings Per Share (EPS) -0.77
EBITDA -0.43
Effective Tax Rate (%) -1.96
Particulars DEC 2024 (Values in Cr)
Revenue 4.72
Operating Expense 5.60
Net Profit -0.70
Net Profit Margin (%) -14.83
Earnings Per Share (EPS) -1.02
EBITDA -0.60
Effective Tax Rate (%) -1.44
Particulars SEP 2024 (Values in Cr)
Revenue 5.93
Operating Expense 6.79
Net Profit -0.64
Net Profit Margin (%) -10.79
Earnings Per Share (EPS) -0.94
EBITDA -0.57
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 24.37
Operating Expense 26.72
Net Profit -1.59
Net Profit Margin (%) -6.52
Earnings Per Share (EPS) -2.33
EBITDA -1.26
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 30.59
Operating Expense 31.80
Net Profit -0.52
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) -0.76
EBITDA -0.16
Effective Tax Rate (%) 5.45
Particulars MAR 2023 (Values in Cr)
Revenue 27.49
Operating Expense 29.43
Net Profit -1.26
Net Profit Margin (%) -4.58
Earnings Per Share (EPS) -1.84
EBITDA -1.02
Effective Tax Rate (%) 11.88
Particulars MAR 2022 (Values in Cr)
Revenue 17.22
Operating Expense 19.24
Net Profit -1.55
Net Profit Margin (%) -9.00
Earnings Per Share (EPS) -2.27
EBITDA -1.27
Effective Tax Rate (%) 1.28
Particulars MAR 2021 (Values in Cr)
Revenue 19.90
Operating Expense 20.31
Net Profit 0.31
Net Profit Margin (%) 1.55
Earnings Per Share (EPS) 0.46
EBITDA 0.83
Effective Tax Rate (%) 35.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 6.58
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -5.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -0.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.45
ROE % -17.98
ROCE % -17.75
Total Debt to Total Equity 0.00
EBITDA Margin -7.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.79
ROE % 3.34
ROCE % 5.02
Total Debt to Total Equity 0.01
EBITDA Margin 5.10
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 21.56
Total Liabilities 21.56
Total Equity 8.73
Share Outstanding 6826960
Price to Book Ratio 4.45
Return on Assets (%) -7.37
Return on Capital (%) -18.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.63
Total Assets 31.44
Total Liabilities 31.44
Total Equity 10.29
Share Outstanding 6826960
Price to Book Ratio 3.28
Return on Assets (%) -1.64
Return on Capital (%) -5.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 28.42
Total Liabilities 28.42
Total Equity 10.80
Share Outstanding 6827000
Price to Book Ratio 2.43
Return on Assets (%) -4.43
Return on Capital (%) -11.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 21.20
Total Liabilities 21.20
Total Equity 12.05
Share Outstanding 6827000
Price to Book Ratio 2.70
Return on Assets (%) -7.29
Return on Capital (%) -12.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 21.91
Total Liabilities 21.91
Total Equity 13.65
Share Outstanding 6826960
Price to Book Ratio 1.80
Return on Assets (%) 1.42
Return on Capital (%) 2.28
Particulars MAR 2025 (Values in Cr)
Net Income -1.60
Cash from Operations 0.00
Cash from Investing -0.12
Cash from Financing -0.14
Net change in Cash -0.26
Free Cash Flow 0.16
Particulars MAR 2024 (Values in Cr)
Net Income -0.54
Cash from Operations 0.10
Cash from Investing 0.00
Cash from Financing -0.16
Net change in Cash -0.05
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income -1.43
Cash from Operations 0.64
Cash from Investing -0.01
Cash from Financing -0.16
Net change in Cash 0.47
Free Cash Flow 0.67
Particulars MAR 2022 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.16
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income 0.47
Cash from Operations 0.49
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash 0.22
Free Cash Flow 0.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.33 14.87 1.57 232.43 29.10 / 68.00
BLISS GVS PHARMA LTD 159.85 15.41 1.49 1689.98 105.05 / 190.65
CIPLA LTD 1511.35 22.44 3.70 122082.50 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 278.70 7.32 2.09 820.24 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2496.80 44.37 24.76 42297.30 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.33 24.66 4.22 232.43 29.10 / 68.00
AMRUTAJAN HEALTH LTD 696.30 35.51 5.88 2013.05 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8993.95 97.26 28.14 22484.88 6222.35 / 10653.05
BLISS GVS PHARMA LTD 159.85 21.57 1.53 1689.98 105.05 / 190.65

PHAARMASIA LTD. shareholding pattern

Holding

26.42%
73.51%
0.05%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

PHAARMASIA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
49.08 4.98 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 44.10
  • 26 Days 37.30
  • 10 Days 40.70
  • 50 Days 35.80
  • 12 Days 39.90
  • 100 Days 34.90
  • 20 Days 38.00
  • 200 Days 35.60
46.75 PIVOT

First Support

46.75

First Resistance

46.75

Second Support

46.75

Second Resistance

46.75

Third Support

46.75

Third Resistance

46.75

RSI

77.93

ADX

15.91

MACD

2.62

Williams % R

0.00

Commodity Channel Index (CCI)

227.22

Date

2025-11-21

Week

2945.00

Same Day

10314.00

Month

1557.00

1 Year

0.40

3 Year

0.33

Over 1 Month

36.33%

down

Over 1 Year

5.70%

down

Over 3 Months

64.53%

down

Over 3 Years

22.04%

down

Over 6 Months

65.19%

down

Over 5 Years

13.54%

down

PHAARMASIA LTD. Corporate Actions

PHAARMASIA LTD. Share Price

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports.

The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum.

During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP
certified and ISO 9001-certified manufacturing facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Phaarmasia Ltd?

Answer Field

Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 49.08 as on Nov 21 2025 03:04 PM.

What is the Market Cap of Phaarmasia Ltd Share?

Answer Field

The market cap of Phaarmasia Ltd for NSE ₹ 0.00 & for BSE ₹ 33.50 as on Nov 21 2025 03:04 PM.

What is the 52 Week High and Low of Phaarmasia Ltd?

Answer Field

The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 61.95 and ₹ 23.60.

What is 1 year return for Phaarmasia Ltd?

Answer Field

The 1 year returns on the stock has been 5.70%.

What is the P/E Ratio of Phaarmasia Ltd Share?

Answer Field

As on Nov 21 2025 03:04 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is 43.05.

What is the PB ratio of Phaarmasia Ltd Share?

Answer Field

As on Nov 21 2025 03:04 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 9.52.

How to Buy Phaarmasia Ltd Share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

Answer Field

To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Phaarmasia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59